# A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines

> **NCT07756580** · PHASE1 · RECRUITING · sponsor: **AbbVie** · enrollment: 120 (estimated)

## Conditions studied

- Glabellar Lines

## Interventions

- **DRUG:** AGN-151586
- **DRUG:** BOTOX

## Key facts

- **NCT ID:** NCT07756580
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-10
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07756580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07756580, "A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07756580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*